1. Single cell RNA-seq uncovers the nuclear decoy lincRNA PIRAT as a regulator of systemic monocyte immunity during COVID-19
- Author
-
Kim Pauck, Sarah M. Volkers, Leon N. Schulte, Daniel Wendisch, Margrit Guendisch, Yang Li, Judith Hoppe, Christian Keller, Elisabeth Mack, Philipp Georg, Christian Bauer, Andrea Nist, Holger Garn, Wilhelm Bertrams, Harshavardhan Janga, Marina Aznaourova, Leif E. Sander, Chrysanthi Skevaki, Thorsten Stiewe, Achim D. Gruber, Clemens Ruppert, Zhenhua Zhang, Nils Schmerer, and Bernd Schmeck
- Subjects
medicine.anatomical_structure ,Pseudogene ,Transgene ,Monocyte ,medicine ,RNA ,Promoter ,Biology ,Non-coding RNA ,Decoy ,Transcription factor ,Cell biology - Abstract
The systemic immune response to viral infection is shaped by master transcription factors such as NFκB or PU.1. Although long non-coding RNAs (lncRNAs) have been suggested as important regulators of transcription factor activity, their contributions to the systemic immunopathologies observed during SARS-CoV-2 infection have remained unknown. Here, we employed a targeted single-cell RNA-seq approach to reveal lncRNAs differentially expressed in blood leukocytes during severe COVID-19. Our results uncover the lncRNA PIRAT as a major PU.1 feedback-regulator in monocytes, governing the production of the alarmins S100A8/A9 – key drivers of COVID-19 pathogenesis. Knockout and transgene expression, combined with chromatin-occupancy profiling characterized PIRAT as a nuclear decoy RNA, diverting the PU.1 transcription factor from alarmin promoters to dead-end pseudogenes in naïve monocytes. NFκB-dependent PIRAT down-regulation during COVID-19 consequently releases a transcriptional brake, fueling alarmin production. Our results suggest a major role of nuclear noncoding RNA circuits in systemic antiviral responses to SARS-CoV-2 in humans.
- Published
- 2021
- Full Text
- View/download PDF